Partner Content Partner Content Immuno-Oncology 2018 News: MHRA Interview and New Speaker Im... Just Over 1 Week Until Immuno-Oncology 2018 Commences
News EMA freezes UK representatives out of drug reviews as Brexit... The UK’s drugs regulator is increasingly being frozen out of work with the European Medicines Agency (EMA) according to a press report, dealing a blow to the government’s hopes that it coul
Partner Content Partner Content Talks from the MHRA, Innovate UK, Plasticell and more Cell and Gene Therapy
Partner Content Partner Content From Manufacturing to Patient Access: SMi’s Cell & Gene ... Cell & Gene Therapy
Partner Content Partner Content Discover the Future of Pharmaceutical Technology Within Lyop... Pharmaceutical Freeze Drying Technology
Partner Content Partner Content 3 Key Reasons to Attend the 5th Drug Safety conference in Lo... Drug Safety
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
